Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Current Leases (2019 - 2025)

Collegium Pharmaceutical has reported Current Leases over the past 7 years, most recently at $1.4 million for Q4 2025.

  • Quarterly results put Current Leases at $1.4 million for Q4 2025, up 10.7% from a year ago — trailing twelve months through Dec 2025 was $1.4 million (up 10.7% YoY), and the annual figure for FY2025 was $1.4 million, up 10.7%.
  • Current Leases for Q4 2025 was $1.4 million at Collegium Pharmaceutical, up from $1.4 million in the prior quarter.
  • Over the last five years, Current Leases for COLL hit a ceiling of $1.4 million in Q4 2025 and a floor of $750000.0 in Q1 2021.
  • Median Current Leases over the past 5 years was $1.1 million (2022), compared with a mean of $1.1 million.
  • Biggest five-year swings in Current Leases: surged 57.07% in 2022 and later decreased 19.82% in 2023.
  • Collegium Pharmaceutical's Current Leases stood at $814000.0 in 2021, then surged by 36.61% to $1.1 million in 2022, then dropped by 11.15% to $988000.0 in 2023, then rose by 28.64% to $1.3 million in 2024, then increased by 10.7% to $1.4 million in 2025.
  • The last three reported values for Current Leases were $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.